Ampio Pharmaceuticals Inc Stock News
$0.242
+0.0216 (+9.82%)
At Close: May 17, 2024
Ampio Appoints Moss Adams LLP as the Company's New Independent Auditor
12:30pm, Thursday, 11'th Jul 2019
ENGLEWOOD, Colo., July 11, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a development stage biopharmaceutical company focused on the discovery and development of a novel th
Ampio Appoints Dan Stokely as the Company's new Chief Financial Officer
12:30pm, Wednesday, 10'th Jul 2019
ENGLEWOOD, Colo., July 10, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a development stage biopharmaceutical company focused on the discovery and development of a novel th
Have Investors Given Up On Antero Resources Corporation (AR), Ampio Pharmaceuticals, Inc. (AMPE)? | Post Analyst
01:00pm, Monday, 08'th Jul 2019
Jul 05 was a weak volume day for , with an upside momentum. The trading capacity for the firm moved to 5877644 contracts. Over the past week, the average daily trading volume stood at about 8316980 sh
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering
08:01pm, Wednesday, 19'th Jun 2019
The Company intends to use the net proceeds from this offering for the full cost of its AP-013 clinical trial, titled "A Randomized, Controlled, Double-Blind Study to Evaluate the Efficacy and Safety
Ampio Pharmaceuticals Announces Pricing of Public Offering
12:16pm, Monday, 17'th Jun 2019
The Company intends to use the net proceeds from this offering for the full cost of its AP-013 clinical trial pursuant to its recently announced Special Protocol Assessment and other general corporate
Mid-Afternoon Market Update: Crude Oil Down 1.5%; C&J Energy Services Shares Spike Higher
12:00am, Monday, 17'th Jun 2019Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
08:01pm, Friday, 14'th Jun 2019
ENGLEWOOD, Colo., June 14, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio"), today announced that it intends to offer and sell shares of its common stock in an underwr
Ampio Regulatory and Clinical Update
11:30am, Friday, 14'th Jun 2019
According to Michael Macaluso, Ampio CEO, "The Company has identified and engaged 15 clinical sites for the trial (AP-013) and patient identification is underway. This pivotal trial seeks to enroll
